Aldosterone glucuronidation inhibition as a potential mechanism for arterial dysfunction associated with chronic celecoxib and diclofenac use in patients with rheumatoid arthritis
Crilly, M. A., Mangoni, A. A., Knights, K. M.
Clinical and Experimental Rheumatology, vol. 31, no. 5, pp. 691-698
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Al-Chalabi, A., Allen, C., Counsell, C. E., Farrin, A., Dickie, B., Kelly, J., Leigh, P., Murphy, C., Payan, C., Reynolds, G., Shaw, P., Steen, I., Thornhill, M., Waters, J., Zajicek, J., Young, C. A., Morrison, K. E., Dhariwal, S., Hornabrook, R., Savage, L., Burn, D. J., Khoo, T. K., Kelly, J., Dougherty, A., Wijesekera, L., Thornhill, M., Ellis, C. M., O'Hanlon, K., Panicker, J., Pate, L., Ray, P., Wyatt, L., Copeland, L., Ealing, J., Hamdalla, H., Leroi, I., Murphy, C., O'Keeffe, F., Oughton, E., Partington, L., Paterson, P., Rog, D., Sathish, A., Sexton, D., Smith, J., Vanek, H., Dodds, S., Williams, T. L., Clarke, J., Eziefula, C., Howard, R., Orrell, R., Sidle, K., Sylvester, R., Barrett, W., Merritt, C., Talbot, K., Turner, M. R., Whatley, C., Williams, C., Williams, J., Cosby, C., Hanemann, C. O., Imam, I., Phillips, C., Timings, L., Crawford, S. E., Hewamadduma, C., Hibberd, R., Hollinger, H., McDermott, C., Mills, G., Rafiq, M., Taylor, A., Waines, E., Walsh, T., Addison-Jones, R., Birt, J., Hare, M., Majid, T.